在心血管-脏-代谢综合征中,HIF介导的果糖代谢和疾病进展
David Mathew1, Sean Davidson1, Derek Yellon1
1The Hatter Cardiovascular Institute, University College London, London, UK.
Comprehensive Physiology
|August 11, 2025
概括
果糖代谢由Ketohexokinase-C调节,将心血管-脏-代谢综合征的组成部分联系起来. 抑制这种途径可能会改善受影响患者的心脏结果.
科学领域:
- 生物化学 生物化学
- 病理生理学 病理生理学
- 心血管医学 心血管医学
背景情况:
- 心血管代谢综合征涉及多器官功能障碍和不良心脏事件.
- 通过Ketohexokinase-C的果糖代谢与这种综合征的病理生理学有关.
- 在缺血期间,HIF-1α会诱导心脏凯托赫索金酶-C的表达,从而导致功能障碍.
研究的目的:
- 研究果糖代谢在心血管-脏-代谢综合征中的作用.
- 探索HIF-1α稳定对心脏的潜在影响,特别是关于Ketohexokinase-C.
- 确定治疗目标,以改善这种综合征中的心脏结果.
主要方法:
- 关于果糖代谢,器官交叉交流和HIF-1α的现有文献的综述.
- 分析果糖代谢,炎症和器官功能障碍之间的机制联系.
- 考虑关于慢性病中贫血治疗的临床数据.
主要成果:
- 果糖代谢与心血管-脏-代谢综合征有机械联系.
- 由HIF-1α诱导的心脏凯托赫索金酶-C表达,有助于心脏缩和功能障碍.
- 稳定HIF-1α的药物引起了人们的担忧,因为它们可能会对心脏产生性心脏作用.
结论:
- 果糖代谢是心血管-脏-代谢综合征的关键参与者.
- 研究HIF稳定对心脏生理学的类效应至关重要.
- 对Ketohexokinase-C的药理抑制是改善心脏结果的潜在策略.
相关概念视频
Overview of Carbohydrate Metabolism
1.8K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.8K
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure I: Introduction
55
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
55
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
Chronic Kidney Disease II: Clinical Manifestations
91
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
91


